Comparison of Laser Hemorrhoidoplasty Versus Conventional Milligan Morgan Hemorrhoidectomy in Grade II and III Hemorrhoids
LHP-MMH
1 other identifier
interventional
96
1 country
1
Brief Summary
Hemorrhoidal disease is one of the most common anorectal disorders. Conventional Milligan Morgan Hemorrhoidectomy remains the standard treatment but is associated with considerable postoperative pain. Laser Hemorrhoidoplasty has emerged as a minimally invasive alternative. This randomized controlled trial compares postoperative pain, patient satisfaction, and hospital stay between Laser Hemorrhoidoplasty and conventional hemorrhoidectomy in patients with Grade II and Grade III hemorrhoids.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedFirst Submitted
Initial submission to the registry
June 25, 2026
CompletedFirst Posted
Study publicly available on registry
July 1, 2026
CompletedJuly 1, 2026
June 1, 2026
6 months
June 25, 2026
June 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postoperative Pain
Pain measured using Visual Analogue Scale (VAS).
Post Operative period: (6) Six Hourly in first 48 Hours, at 1 week post operative period & at 1 month post operatively.
Patient Satisfaction
Patient satisfaction assessed using Likert-scale questionnaire.
1 month postoperative
Study Arms (2)
Laser Hemorrhoidoplasty
EXPERIMENTALPatients underwent Laser Hemorrhoidoplasty using diode laser energy applied to hemorrhoidal tissue.
Milligan Morgan Hemorrhoidectomy
ACTIVE COMPARATORPatients underwent conventional open Milligan Morgan Hemorrhoidectomy.
Interventions
Patients randomized to the intervention group underwent Laser Hemorrhoidoplasty under spinal anesthesia. A diode laser probe was introduced into the hemorrhoidal tissue through a small mucosal entry point under direct visualization using an anoscope. Controlled laser energy was delivered submucosally to achieve coagulation, shrinkage, and fixation of the hemorrhoidal cushions while preserving the surrounding anoderm and mucosa. The procedure was performed according to standard surgical protocols with the aim of reducing postoperative pain, bleeding, and recovery time.
Patients randomized to the control group underwent conventional open Milligan Morgan Hemorrhoidectomy under spinal anesthesia. The hemorrhoidal pedicles were identified, ligated, and excised using standard surgical techniques. The wounds were left open with preservation of mucocutaneous bridges between excision sites. Hemostasis was achieved as required. Patients received routine postoperative care and follow-up according to institutional protocols.
Eligibility Criteria
You may qualify if:
- Age ≥18 years Grade II hemorrhoids Grade III hemorrhoids Both genders
You may not qualify if:
- Rectal prolapse Anal fissure Anorectal malignancy Pregnancy or lactating mothers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jinnah Hospital, Lahore.
Lahore, Punjab Province, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Muhammad, FCPS General Surgery Resident
Study Record Dates
First Submitted
June 25, 2026
First Posted
July 1, 2026
Study Start
September 1, 2025
Primary Completion
February 28, 2026
Study Completion
March 31, 2026
Last Updated
July 1, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
Individual participant data collected during the study will not be made publicly available. Data will remain confidential and will be retained by the investigators in accordance with institutional policies and ethical approval requirements.